Alzheimer disease: Amyloid-targeting antibody performs well in phase II trial
Nat Rev Neurol
.
2011 Dec 7;7(12):657.
doi: 10.1038/nrneurol.2011.183.
Author
Katie Kingwell
PMID:
22146778
DOI:
10.1038/nrneurol.2011.183
No abstract available
Publication types
Comment